Andrew J. Last
Director · Insight Molecular Diagnostics Inc.
- 2025
- Jul 7, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew J. Last files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BROADWOOD PARTNERS, L.P. - $5.69M in IMDX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew J. Last?
Andrew J. Last is a corporate insider, tracked as Director of Insight Molecular Diagnostics Inc. (IMDX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Andrew J. Last last file a Form 4?
The most recent primary Form 4 on record is dated 7 July 2026, one of 3 filings going back to 2025.